Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Experience with donanemab over a 1-year period: observations of side effects and compliance from a regional specialty medical center.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: December 31, 2025
Lecanemab over a two-year duration: Key insights from a regional specialty medical center.
Journal: The journal of prevention of Alzheimer's disease
Published: October 08, 2025
Lecanemab over a two-year duration: Key insights from a regional specialty medical center.
Journal: The journal of prevention of Alzheimer's disease
Published: October 08, 2025
Initial Experience with Lecanemab and Lessons Learned in 71 Patients in a Regional Medical Center.
Journal: The journal of prevention of Alzheimer's disease
Published: November 19, 2024
Showing 1-4 of 4
Last Updated: 09/26/2026